12
Views
4
CrossRef citations to date
0
Altmetric
Original Article

A Double-Blind, Placebo-Controlled Trial of the Thromboxane Synthetase Blocker OKY-046 on Bronchial Hypersensitivity in Bronchial Asthma Patients

, , , &
Pages 355-360 | Published online: 02 Jul 2009

References

  • American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987; 136: 225–244
  • Boushey H A, Holzman M J, Scheller J R, Nadal L A. Bronchial hyperreactivity. Am Rev Respir Dis 1980; 121: 384–413
  • Chai H, Farr R S, Froehlick L A, Mathison D A, McLean J A, Rosenthal R R, Sheffer A L, Spector S L, Townley R G. Standardization of bronchial inhalation challenge procedures. J Allergy Clin Immunol 1975; 56: 323–327
  • Orehek J, Gayrard P, Smith A P, Grimaud C, Charpin J. Airway response to carbochol in normal and asthmatic subjects: distinction between bronchial sensitivity and reactivity. Am Rev Respir Dis 1977; 115: 937–943
  • Svensson J, Strandberg K, Tuvemo T, Hamberg M. Thromboxane A2: effects on airway and vascular smooth muscle. Prostaglandins 1977; 14: 425–436
  • Wenzel S E, Westcott J Y, Smith H R, Larsen G. Spectrum of prostanoid release after bronchoalveolar allergen challenge in atopic asthmatic and in control groups. Am Rev Respir Dis 1989; 139: 450–457
  • Aizawa H, Chung K F, Leikauf G D, Ueki I, Bethel R A, O'Byrne P M, Hirose T, Nadel J A. Significance of thromboxane generation in ozone-induced airway hyperresponsiveness in dogs. J Appl Physiol 1985; 59: 1918–1923
  • Fujiinura M, Saito M, Kurushima K, Miyake Y, Sakamoto S, Matsuda T. Bronchoconstrictive properties and potentiating effect on bronchial responsiveness of inhaled thromboxane A2 analogue (STA2) in guinea pigs. J Asthma 1989; 26: 237–242
  • O'Byrne P M, Fuller R W. The role of thromboxane A2 in the pathogenesis of airway hyperresponsiveness. Eur Respir J 1989; 2: 782–786
  • Naito J, Komatsu H, Ujiie A, Hamano A, Kubota T, Tsuboshima M. Effects of thromboxane synthetase inhibitors on aggregation of rabbit platelets. Eur J Pharmacol 1983; 91: 41–48
  • Fujimura M, Koshino K, Nishioka S, Matsuda T. Involvement of thromboxane A2 in SRS-A mediated bronchoconstriction induced by aerosol antigen in the guinea pigs. Kokyu to Junkan 1984; 3: 1066–1071
  • Fujimura M, Miyake Y, Uotani K, Kanamori K, Matuda T. Secondary release of thromboxane A2 in aerosol leukotriene C4-induced bronchoconstriction in guinea pigs. Prostaglandins 1988; 35: 427–437
  • Fujimura M, Sasaki F, Nakatsumi Y, Takahashi Y, Hifumi S, Taga K, Mifune J, Tanaka T, Matsuda T. Effects of a thromboxane synthetase inhibitor (OKY-046) and a lipoxygenase inhibitor (AA-861) on bronchial responsiveness to acetylcholine in asthmatic subjects. Thorax 1986; 41: 955–959
  • Fujimura M, Nishioka S, Kumabashiri I, Matsuda T, Mifune J. Effects of aerosol administration of a thromboxane synthetase inhibitor (OKY-046) on bronchial responsiveness to acetylcholine in asthmatic subjects. Chest 1990; 98: 276–279
  • Fujimura M, Sakamoto S, Matsuda T. Attenuating effect of a thromboxane synthetase inhibitor (OKY-046) on bronchial responsiveness to methacholine is specific to bronchial asthma. Chest 1990; 98: 656–660
  • Takishima T, Hida W, Suzuki S, Sasaki T. Direct graphical recordings of the cumulative dose-response curves of the airway to methacholine in normal, bronchitic and asthmatic subjects. Tohoku J Exp Med 1981; 135: 117–137
  • Takishima T, Hida W, Sasaki H, Suzuki S, Sasaki T. Direct-writing recorder of the dose-response curves of the airway to methacholine: clinical application. Chest 1981; 80: 600–606
  • Liu Y-N, Sasaki H, Ishii M, Sekizawa K, Hida W, Ichinose M, Takishima T. Effect of circadian rhythm on bronchomotor tone after deep inspiration in normal and in asthmatic subjects. Am Rev Respir Dis 1985; 132: 278–282
  • Hamberg M, Svensson J, Samuelsson B. Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci USA 1975; 72: 2994–2998
  • Maurin N. Routine measurement of thromboxane B2 and the prostacyclin metabolite 6-keto-prostaglandin F1α in plasma. Drug Res 1986; 36: 1174–1179
  • Thorngren M, Vinge E. Thromboxane A2 and prostacycline release in bleeding time blood during primary haemostasis in healthy individuals. Acta Med Scand 1988; 223: 187–190
  • Barnes P J, Chung K F, Page C P. Inflammatory mediators and asthma. Pharmacol Rev 1988; 40: 49–84
  • Alabaster V A, Moore B A. Drug intervention in asthma: present and future. Thorax 1993; 48: 176–182
  • Hardy C, Robinson C, Lewis R A, Tattersfield A E, Holgate S T. Airway and cardiovascular responses to inhaled prostacyclin in normal and asthmatic subjects. Am Rev Respir Dis 1985; 131: 18–21
  • Fujimura M, Sakamoto S, Saito M, Miyake Y, Matsuda T. Effect of a thromboxane A2 receptor antagonist (AA-2414) on bronchial hyperresponsiveness to methacholine in subjects with asthma. J Allergy Clin Immunol 1991; 87: 23–27

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.